Raymond James & Associates’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-8,515
Closed -$242K 3469
2018
Q1
$242K Buy
+8,515
New +$242K ﹤0.01% 3015